Caribbean Gold Standard Laboratory

Caribbean Gold Standard Laboratory (CGS) is an active contract research organization specializing in analytical testing and processing of pharmaceutical compounds, including psychedelics and cannabis. While not a primary drug developer, CGS collaborates under partnership with Neural Therapeutics Inc. to advance clinical trial programs focused on mescaline-based therapies for mental health disorders. The company is not currently at late-stage clinical development, but is involved in extraction technology optimization and pre-clinical work. No independent clinical results are available; their primary role is in supporting drug development through analytical services.